Edwards Lifesciences Says FDA Approves AUTUS Size-Adjustable Valve, Surgical Pulmonary Valve Designed For Pediatric Patients With Congenital Heart Disease

Edwards Lifesciences (NYSE: EW) announced FDA approval for the AUTUS Size-Adjustable Valve, a surgical pulmonary valve tailored for pediatric patients with congenital heart disease requiring valve replacement. This valve is notable for its ability to expand as the child grows, which may decrease the necessity for repeat open-heart surgeries through a minimally invasive transcatheter procedure.